Home | Contact Us | Search | Site Map
About Us Technology Products R&D Partners Investors Media Careers Hidden
Crucell
STAR® Technology



  PER.C6® Technology
  Vaccine Technology
  Protein Technology
  PER.C6® Technology
  STAR® Technology
  Description
  Applications
  Licensing
  MAbstract® Technology
  Partnering Opportunities

Key Strengths
  • Established mammalian cell banks for protein and antibody production are the starting point for STAR® technology, thus specially engineered mammalian cells are not needed.

 

  • The STAR® technology allows for very rapid stable mammalian cell clone generation.

 

  • The STAR® technology typically yields stable mammalian cell clones that produce 5 to 10 fold higher antibody or other therapeutic proteins as compared to cell clones generated without STAR® technology. 
  E-mail this page   Print this page

    Home  |  Contact Us  |  Search  |  Site Map  |  
MoveNext - Latus © Crucell 2006 | Disclaimer